Bun Sok-Sithikun, Lațcu Decebal Gabriel, Taghji Philippe, Anselme Frederic, Boveda Serge, Cebron Jean-Pierre, Defaye Pascal, Deharo Jean-Claude, Fauchier Laurent, Gandjbakhch Estelle, Gras Daniel, Klug Didier, Mansourati Jacques, Marijon Eloi, Maury Jean-Philippe, Squara Fabien, Saoudi Nadir, Taïeb Jérôme
Department of Cardiology Princess Grace Hospital Monaco (Principality).
Private Hospital Clairval Marseille France.
J Arrhythm. 2019 Feb 15;35(2):238-243. doi: 10.1002/joa3.12165. eCollection 2019 Apr.
Combination of elementary parameters (force, time, power, impedance drop) has been proposed to optimize radiofrequency (RF) delivery. They have been partially validated in clinical studies.
The aim of this study was to assess contact-force (CF) implementation into clinical practice.
A 36-question electronic form was sent to 105 electrophysiologists (EP) including some general questions concerning the practice of catheter atrial fibrillation ablation and items concerning the parameters used for CF-guided ablation.
Answers from 98 EP were collected (93% response rate). The CF-catheters used were Smart Touch, Biosense (52%), Tacticath, Saint-Jude Medical (12%), or both (27%) and no CF (9%). The power applied on the left atrial (LA) anterior (LAAW) and posterior (LAPW) wall was, respectively, 26-34 W (for 73% of the EP) and below 25 W (88% of the EP). Forty percent of the Visitag users mostly used the nominal parameters. Seventy-five percent of the users did not use automatic display of the impedance drop. For the Tacticath users, 57% used a target value of 400 gs on the LAAW and 300 to 400 gs on the LAPW. Lesion Size Index was exceptionally used.
The parameters used for CF-guided ablation are widely variable among the different operators. Further prospective studies are needed to validate the targets for automatic annotation of the RF applications.
有人提出结合基本参数(力、时间、功率、阻抗下降)来优化射频(RF)传递。它们已在临床研究中得到部分验证。
本研究的目的是评估接触力(CF)在临床实践中的应用情况。
向105位电生理学家(EP)发送了一份包含36个问题的电子表格,其中包括一些关于导管消融治疗心房颤动实践的一般性问题,以及关于CF引导消融所用参数的问题。
收集到了98位EP的回复(回复率为93%)。所使用的CF导管为Smart Touch、Biosense(52%)、Tacticath、圣犹达医疗(12%),或两者皆用(27%),未使用CF的占9%。施加在左心房(LA)前壁(LAAW)和后壁(LAPW)的功率分别为26 - 34W(73%的EP)和低于25W(88%的EP)。40%的Visitag用户大多使用标称参数。75%的用户未使用阻抗下降自动显示功能。对于Tacticath用户,57%在LAAW上使用400gs的目标值,在LAPW上使用300至400gs的目标值。极少使用病变大小指数。
不同操作者用于CF引导消融的参数差异很大。需要进一步的前瞻性研究来验证RF应用自动标注的目标。